Skip to main content

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-04-2010 | Original article

Neurohormonal profile of patients with heart failure and diabetes

Auteurs: I. C. C. van der Horst, R. A. de Boer, H. L. Hillege, F. Boomsma, A. A. Voors, D. J. van Veldhuisen

Gepubliceerd in: Netherlands Heart Journal | Uitgave 4/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Extract

Diabetes is a significant independent risk factor for developing chronic heart failure (HF). The prevalence of diabetes in the general population is now at least 5%, and current large trials show that this is around 30% in patients with chronic HF, while it may be close to 50% in those with acute HF.1-4 In the most recent Heart Failure Guidelines of the European Society of Cardiology the increasing importance of diabetes in HF is well recognised.5 In the Framingham study the relative risk for developing HF was 2.36 in diabetic men aged 45 to 74 years and 5.14 in diabetic women compared with non-diabetics.6 Patients with mild HF and diabetes have a worse prognosis than those without diabetes.7
Literatuur
1.
go back to reference De Groote P, Lamblin N, Mouquet F, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J. 2004;25:656-62. De Groote P, Lamblin N, Mouquet F, et al. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J. 2004;25:656-62.
2.
go back to reference Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 2001;38:42-8. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 2001;38:42-8.
3.
go back to reference Jaarsma T, Van der Wal MH, Lesman-Leegte I, et al., for the COACH Study Group. Effect of moderate or intensive disease management program on outcome in patients with heart failure. The Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH). Arch Intern Med. 2008;168:316-24. Jaarsma T, Van der Wal MH, Lesman-Leegte I, et al., for the COACH Study Group. Effect of moderate or intensive disease management program on outcome in patients with heart failure. The Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure (COACH). Arch Intern Med. 2008;168:316-24.
4.
go back to reference McMurray JJ, Teerlink JR, Cotter G, et al., for the VERITAS Investigators. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure. The VERITAS randomized controlled trials. JAMA. 2007;298:2009-19. McMurray JJ, Teerlink JR, Cotter G, et al., for the VERITAS Investigators. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure. The VERITAS randomized controlled trials. JAMA. 2007;298:2009-19.
5.
go back to reference Dickstein K, Cohen-Solal A, Filippatos G, et al., on behalf of the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Eur J Heart Fail. 2008;10:933-89. Dickstein K, Cohen-Solal A, Filippatos G, et al., on behalf of the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Eur J Heart Fail. 2008;10:933-89.
6.
go back to reference Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34:29-34. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34:29-34.
7.
go back to reference Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 1996;77:1017-20. Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 1996;77:1017-20.
8.
go back to reference Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-66. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-66.
9.
go back to reference Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-54. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-54.
10.
go back to reference Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-85. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-85.
11.
go back to reference Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond). 1996;90:189-95. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond). 1996;90:189-95.
12.
go back to reference Hampton JR, Van Veldhuisen DJ, Kleber FX, et al, for the Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME-II) Investigators. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet. 1997;349:97-7. Hampton JR, Van Veldhuisen DJ, Kleber FX, et al, for the Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME-II) Investigators. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet. 1997;349:97-7.
13.
go back to reference Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van den Berg MP, De Kam PJ, Crijns HJ. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol. 1998;81:1207-10. Tuinenburg AE, Van Veldhuisen DJ, Boomsma F, Van den Berg MP, De Kam PJ, Crijns HJ. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol. 1998;81:1207-10.
14.
go back to reference Hogenhuis J, Voors AA, Jaarsma T, Hillege HL, Boomsma F, Van Veldhuisen DJ. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7:8-6. Hogenhuis J, Voors AA, Jaarsma T, Hillege HL, Boomsma F, Van Veldhuisen DJ. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7:8-6.
15.
go back to reference Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-) ANP and (NT-pro) BNP. Europace. 2006;8:482-7. Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-) ANP and (NT-pro) BNP. Europace. 2006;8:482-7.
16.
go back to reference Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82:1730-6. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82:1730-6.
17.
go back to reference Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292-9. Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292-9.
18.
go back to reference Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care. 2004;27:1929-35. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care. 2004;27:1929-35.
19.
go back to reference Bhalla MA, Chiang A, Epshteyn VA, et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2004;44:1047-52. Bhalla MA, Chiang A, Epshteyn VA, et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2004;44:1047-52.
20.
go back to reference Albertini JP, Cohen R, Valensi P, Sachs RN, Charniot JC. B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients. Diabetes Metab. 2008;34:355-62. Albertini JP, Cohen R, Valensi P, Sachs RN, Charniot JC. B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients. Diabetes Metab. 2008;34:355-62.
21.
go back to reference Kindermann M, Reil JC, Piekse B, Van Veldhuisen DJ, Böhm M. Heart failure with normal left ventricular ejection fraction (HFNEF): what is the evidence? Trends Cardiovasc Med 2008; 2008;18:280-92. Kindermann M, Reil JC, Piekse B, Van Veldhuisen DJ, Böhm M. Heart failure with normal left ventricular ejection fraction (HFNEF): what is the evidence? Trends Cardiovasc Med 2008; 2008;18:280-92.
22.
go back to reference Pieske B, Wachter R. Impact of diabetes and hypertension on the Heart. Curr Opin Cardiol. 2008;23:340-9. Pieske B, Wachter R. Impact of diabetes and hypertension on the Heart. Curr Opin Cardiol. 2008;23:340-9.
23.
go back to reference Hartog JW, Voors AA, Bakker SJ, Smit AJ, Van Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure; pathophysiological and clinical implications [review]. Eur J Heart Fail. 2007;9:1146-55. Hartog JW, Voors AA, Bakker SJ, Smit AJ, Van Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure; pathophysiological and clinical implications [review]. Eur J Heart Fail. 2007;9:1146-55.
24.
go back to reference Voors AA, De Jong RM. Treating diastolic heart failure. Heart. 2008;94:97-2. Voors AA, De Jong RM. Treating diastolic heart failure. Heart. 2008;94:97-2.
25.
go back to reference Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond). 1996;90:189-95. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG. Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci (Lond). 1996;90:189-95.
26.
go back to reference Hopfner RL, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia. 1999;42:1383-94. Hopfner RL, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia. 1999;42:1383-94.
27.
go back to reference Van Veldhuisen DJ, Charlesworth A, Crijns HJGM, Lie KI, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J. 1999; 20:666-72. Van Veldhuisen DJ, Charlesworth A, Crijns HJGM, Lie KI, Hampton JR. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J. 1999; 20:666-72.
28.
go back to reference Nosadini R, Fioretto P, Giorato C, et al. Sodium metabolism in insulin dependent diabetic patients. Role of insulin and atrial natriuretic peptide. Diabete Metab. 1989;15:30-5. Nosadini R, Fioretto P, Giorato C, et al. Sodium metabolism in insulin dependent diabetic patients. Role of insulin and atrial natriuretic peptide. Diabete Metab. 1989;15:30-5.
29.
go back to reference Barents M, Van der Horst IC, Voors AA, Hilege JL, Muskiet FA, De Jongste MJ. Prevalance and misdiagnosis of chronic heart failure in nursing home residents: the role of B-type natriuretic peptide. Neth Heart J. 2008;16:123-8. Barents M, Van der Horst IC, Voors AA, Hilege JL, Muskiet FA, De Jongste MJ. Prevalance and misdiagnosis of chronic heart failure in nursing home residents: the role of B-type natriuretic peptide. Neth Heart J. 2008;16:123-8.
Metagegevens
Titel
Neurohormonal profile of patients with heart failure and diabetes
Auteurs
I. C. C. van der Horst
R. A. de Boer
H. L. Hillege
F. Boomsma
A. A. Voors
D. J. van Veldhuisen
Publicatiedatum
01-04-2010
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 4/2010
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03091760